$19.5 Million is the total value of Antipodean Advisors LLC's 13 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 112.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
OXY | Buy | OCCIDENTAL PETE CORP | $6,488,000 | +100.6% | 100,000 | +81.8% | 33.24% | +44.9% |
PM | New | PHILIP MORRIS INTL INC | $4,629,000 | – | 50,000 | +100.0% | 23.72% | – |
SE | SEA LTDsponsord ads | $3,076,500 | -24.3% | 70,000 | 0.0% | 15.76% | -45.3% | |
ATRA | ATARA BIOTHERAPEUTICS INC | $1,480,000 | -8.1% | 1,000,000 | 0.0% | 7.58% | -33.6% | |
Buy | INVESTMENT MANAGERS SER TR Iaxs tsla bear dl | $1,299,200 | +14.7% | 40,000 | +14.3% | 6.66% | -17.1% | |
RILY | New | B. RILEY FINANCIAL INC | $435,683 | – | 10,629 | +100.0% | 2.23% | – |
CMAX | Sell | CAREMAX INC | $424,000 | -67.9% | 200,000 | -52.9% | 2.17% | -76.8% |
DLR | New | DIGITAL RLTY TR INC | $423,570 | – | 3,500 | +100.0% | 2.17% | – |
TRUP | New | TRUPANION INC | $423,000 | – | 15,000 | +100.0% | 2.17% | – |
COIN | New | COINBASE GLOBAL INC | $375,400 | – | 5,000 | +100.0% | 1.92% | – |
CDLX | Sell | CARDLYTICS INC | $330,000 | +49.2% | 20,000 | -42.9% | 1.69% | +7.8% |
FUBO | New | FUBOTV INC | $81,168 | – | 30,400 | +100.0% | 0.42% | – |
OPEN | New | OPENDOOR TECHNOLOGIES INC | $52,800 | – | 20,000 | +100.0% | 0.27% | – |
CVNA | Exit | CARVANA COcl a | $0 | – | -10,000 | -100.0% | -1.84% | – |
GDX | Exit | VANECK ETF TRUSTgold miners etf | $0 | – | -75,000 | -100.0% | -16.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CARVANA CO | 21 | Q2 2023 | 38.5% |
AMAZON COM INC | 20 | Q4 2020 | 33.8% |
SEA LTD | 19 | Q3 2023 | 60.8% |
CARDLYTICS INC | 18 | Q3 2023 | 26.3% |
MEDICINES CO | 18 | Q4 2019 | 19.8% |
ATARA BIOTHERAPEUTICS INC | 15 | Q3 2023 | 17.9% |
CONSTELLATION BRANDS INC | 14 | Q4 2016 | 11.1% |
HERBALIFE NUTRITION LTD | 13 | Q1 2021 | 24.8% |
CLARIVATE PLC | 11 | Q4 2021 | 24.4% |
EXACT SCIENCES CORP | 11 | Q2 2019 | 24.6% |
View Antipodean Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Oncothyreon Inc.Sold out | January 09, 2013 | 0 | 0.0% |
View Antipodean Advisors LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
13F-HR | 2021-08-16 |
View Antipodean Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.